BlackRock Health Sciences Opportunities Portfolio Class R
BHSRX
NASDAQ
| Weiss Ratings | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | BlackRock | |||
| Manager/Tenure (Years) | Erin Xie (21), Xiang Liu (5) | |||
| Website | http://www.blackrock.com | |||
| Fund Information | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | BlackRock Health Sciences Opportunities Portfolio Class R | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Sep 12, 2011 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 100.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.02% | |||
| Dividend | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.42% | |||
| Asset Allocation | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 2.41% | |||
| Stock | 97.18% | |||
| U.S. Stock | 90.53% | |||
| Non-U.S. Stock | 6.65% | |||
| Bond | 0.01% | |||
| U.S. Bond | 0.01% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.40% | |||
| Price History | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.13% | |||
| 30-Day Total Return | 0.69% | |||
| 60-Day Total Return | 1.44% | |||
| 90-Day Total Return | -7.55% | |||
| Year to Date Total Return | -3.48% | |||
| 1-Year Total Return | -8.48% | |||
| 2-Year Total Return | 2.15% | |||
| 3-Year Total Return | 14.11% | |||
| 5-Year Total Return | 22.89% | |||
| Price | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $58.11 | |||
| 1-Month Low NAV | $57.24 | |||
| 1-Month High NAV | $59.67 | |||
| 52-Week Low NAV | $56.44 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $71.36 | |||
| 52-Week High Price (Date) | Jul 16, 2024 | |||
| Beta / Standard Deviation | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.52 | |||
| Standard Deviation | 13.29 | |||
| Balance Sheet | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 6.45B | |||
| Operating Ratios | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.46% | |||
| Turnover Ratio | 27.00% | |||
| Performance | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 6.35% | |||
| Last Bear Market Total Return | -6.06% | |||